Source: http://www.moh.gov.sa/en/CCC/PressRe...-09-22-01.aspx
...
-
Today, 08:51 AM
-
Today, 08:50 AM
-
Source: http://www.agweek.com/news/north-dak...ioux-county-nd Anthrax case confirmed in Sioux County, ND By Jenny Schlecht / Agweek Staff Writer on Sep 22, 2017 at 3:00 p.m. BISMARCK, N.D. — North Dakota has had its first confirmed case of anthrax this year in ...Today, 05:57 AM
-
Source: http://www.swtimes.com/news/20170922...n-pox-outbreak Quarantine at Arkansas prison after chicken pox outbreak By The Associated Posted Sep 22, 2017 at 9:56 AM LITTLE ROCK — Corrections officials have quarantined nearly 300 inmates after identifyin...Today, 05:55 AM
-
Virol J. 2017 Sep 18;14(1):180. doi: 10.1186/s12985-017-0842-1.
Characteristics of influenza H13N8 subtype virus firstly isolated from Qinghai Lake Region, China.
Dong J1, Bo H1, Zhang Y1, Dong L1, Zou S1, Huang W1, Liu J1, Wang D2, Shu Y3.
Author information
Abstract
BACKGROUND:
...Today, 01:29 AM -
Arch Med Res. 2017 Apr;48(3):276-283. doi: 10.1016/j.arcmed.2017.06.007.
Decision-making Process by Users and Providers of Health Care Services During the AH1N1 Epidemic Influenza in Mexico: Lessons Learned and Challenges Ahead.
Huízar-Hernández V1, Arredondo A2, Caballero M3, Castro-Ríos A4, Flores-Hernández S5, Pérez-Padilla...Today, 01:27 AM -
Brain Behav Immun. 2017 Sep 15. pii: S0889-1591(17)30423-3. doi: 10.1016/j.bbi.2017.09.008. [Epub ahead of print]
Positive Mood on the Day of Influenza Vaccination Predicts Vaccine Effectiveness: A Prospective Observational Cohort Study.
Ayling K1, Fairclough L2, Tighe P2, Todd I2, Halliday V3, Garibaldi...Today, 01:26 AM -
J Am Board Fam Med. 2017 Sep-Oct;30(5):615-623. doi: 10.3122/jabfm.2017.05.170031.
New Method for Real Time Influenza Surveillance in Primary Care: A Wisconsin Research and Education Network (WREN) Supported Study.
Temte JL1, Barlow S2, Schemmel A2, Temte E2, Hahn DL2, Reisdorf E2, Shult P2, Tamerius J2.
Author
...Today, 01:26 AM -
Intern Med. 2017 Sep 15. doi: 10.2169/internalmedicine.8137-16. [Epub ahead of print]
Bloody Bronchial Cast Formation Due to Alveolar Hemorrhage Associated with H1N1 Influenza Infection.
Okada Y1, Okada A1, Narumiya H1, Iiduka R1, Katsura K2.
Author information
Abs
...Today, 01:23 AM -
Arch Public Health. 2017 Sep 14;75:54. doi: 10.1186/s13690-017-0223-7. eCollection 2017.
Pandemics, public health emergencies and antimicrobial resistance - putting the threat in an epidemiologic and risk analysis context.
MacIntyre CR1,2, Bui CM1.
Author information
...Today, 01:23 AM -
IDCases. 2017 Sep 1;10:49-50. doi: 10.1016/j.idcr.2017.08.016. eCollection 2017.
Bilateral submandibular sialadenitis following influenza A virus infection.
Fujiwara SA1, Kobayashi T2, Ikeda R2, Yasuda K3, Kubota I4, Takeishi Y5.
Author information
Abstract
A 48-year-old...Today, 01:22 AM -
Expert Rev Vaccines. 2017 Sep 19:1-14. doi: 10.1080/14760584.2017.1379396. [Epub ahead of print]
Vaccine approaches conferring cross-protection against influenza viruses.
Vemula SV1, Sayedahmed EE1, Sambhara S2, Mittal SK1.
Author information
Abstract
INTRODUCTIO
...Today, 01:22 AM -
Hum Vaccin Immunother. 2017 Sep 19:0. doi: 10.1080/21645515.2017.1373227. [Epub ahead of print]
MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): a randomized, multicenter, Phase III pediatric trial in Mexico.
Cruz-Valdez A1, Valdez-Zapata G2, Patel SS3, Castelli FV4, Garcia MG5, Jansen WT6, Arora AK7, Heijnen E8.
Author information
Abstract
The poor immune response elicited by trivalent influenza vaccines (TIVs) in children can be enhanced by the addition of adjuvants. This observer-blind, randomized Phase III trial assessed the immunogenicity and safety of the MF59-adjuvanted trivalent influenza vaccine FLUAD® (aTIV) and a non-adjuvanted TIV, in healthy children (aged 6 to 2, showing that the immunogenicity of aTIV was superior to that of TIV for all 3 strains. Solicited adverse events (AEs) were experienced more frequently with aTIV than TIV by younger children (aged 6 to ...Today, 01:21 AM -
Rev Sci Tech. 2017 Apr;36(1):137-145. doi: 10.20506/rst.36.1.2617.
Animal health economics: an aid to decisionmaking on animal health interventions - case studies in the United States of America.
Marsh TL, Pendell D, Knippenberg R.
Abstract
in English, French, Spanish For anima...Today, 01:14 AM -
BMC Infect Dis. 2017 Sep 19;17(1):632. doi: 10.1186/s12879-017-2716-y.
Variation in loss of immunity shapes influenza epidemics and the impact of vaccination.
Woolthuis RG1,2, Wallinga J3, van Boven M3.
Author information
Abstract
BACKGROUND:
Protective antibody immunity against the influenza A virus wanes in 2-7 years due to antigenic drift of the virus' surface proteins. The duration of immune protection is highly variable because antigenic evolution of the virus is irregular. Currently, the variable nature of the duration of immunity has had little attention in analyses of the impact of vaccination, including cost-effectiveness studies.
METHODS:
We developed a range of mathematical transmission models to investigate the effect of variable duration of immunity on the size of seasonal epidemics. The models range from simple conceptual to more realistic, by distinguishing between infection- versus vaccination-induced immunity, by inclusion of primary vaccine failure, by assuming a leaky vaccine, and by the inclusion of age-dependent contact patterns.
RESULTS:
We show that annual variation in the duration of immunity causes large variation in the size of epidemics, and affects the effectiveness...Today, 01:03 AM -
J Microbiol Immunol Infect. 2017 Sep 6. pii: S1684-1182(17)30197-4. doi: 10.1016/j.jmii.2017.08.014. [Epub ahead of print]
Influenza vaccination and risk of respiratory failure in patients with chronic obstructive pulmonary disease: A nationwide population-based case-cohort study.
Huang HH1, Chen SJ2, Chao TF3, Liu CJ4, Chen TJ5, Chou P6, Wang FD7.
Author information
Abstract
BACKGROUND:
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease which causes a considerable disease burden. Patients with COPD are at a higher risk for influenza infection and influenza vaccination are recommended at this high risk patient group. In the current study, we aimed to evaluate the association between influenza vaccination and the risk of respiratory failure (RF) in COPD patients.
METHODS:
From 2001 to 2005, patients with newly diagnosed COPD were identified from the NHIRD, and were followed until 2010. We explored the influenza vaccination rate among this COPD cohort. Furthermore, patients who experienced RF were defined as case group, whereas the others were defined as control group. Baseline characteristic were compared and association between influenza vaccination and RF were evaluated.
RESULTS:
The rate of influenza vaccination was significantly higher in patients age ≥65 years than those age ...Today, 01:02 AM -
Am J Prev Med. 2017 Sep 16. pii: S0749-3797(17)30424-5. doi: 10.1016/j.amepre.2017.07.017. [Epub ahead of print]
Vaccination Coverage of Adolescents With Chronic Medical Conditions.
Hofstetter AM1, Camargo S2, Natarajan K3, Rosenthal SL4, Stockwell MS5.
Author information
Abstract
INTRODUCTION:
Adolescents with chronic medical conditions (CMCs) are at increased risk of vaccine-preventable infections. Little is known about their vaccine uptake.
METHODS:
This retrospective cohort study included 3,989 adolescents aged 11-17 years receiving care at academically affiliated pediatric clinics between August 2011 and June 2013. Data were abstracted from the medical center's electronic health record and immunization registry in 2014. Vaccination coverage, timeliness, and missed opportunities were evaluated and analyzed in 2015-2016.
RESULTS:
Adolescents with CMCs had lower human papillomavirus vaccination initiation than those without...Today, 12:59 AM -
Vaccine. 2017 Sep 16. pii: S0264-410X(17)31232-X. doi: 10.1016/j.vaccine.2017.09.016. [Epub ahead of print]
Influenza vaccine use to protect healthy children: A debated topic.
Principi N1, Esposito S2.
Author information
Abstract
At the beginning of this century, a number of studies suggested that in healthy children, particularly those <2years of age, influenza could have a serious and complicated course, as it frequently led to hospitalization and sometimes, albeit rarely, to death. Moreover, pre-schoolers and school-age children were found to be among the most important causes of influenza transmission to the community, as they shed the virus for a longer time than adults and had frequent contact with greater numbers of individuals through day-care and school. These findings led a number of health authorities to modify the official recommendations regarding the use of influenza vaccine in healthy children. Several factors seem to indicate that vaccination against influenza in healthy children of any age and in pregnant women could be effective in preventing the disease in the entire paediatric population and in providing herd immunity in adults and old people as well. The direct advantages of the vaccine seem greater in younger subjects, particularly those <2-3years of age. Vaccination of older children is considered effective by most experts, but high vaccination coverage of these subjects has been difficult to attain. Similar difficulties have been identified for the vaccination of pregnant women. These challenges can be overcome, at least in part, by appropriate information and accurate evaluations of available data. In addition, further studies specifically designed to clarify unresolved problems regarding vaccine use in paediatric and pregnant populations are needed to convince reluctant health authorities. More effective vaccines for younger children as well as improved availability of data regarding the optimal time period for vaccine administration in pregnant women appear relevant in this regard.
Copyright © 2017 Elsevier Ltd. All rights reserved.
KEYWORDS:
Children; Influenza; Influenza vaccine; Maternal immunization; Pregnancy PMID: 28928077 DOI: ...Today, 12:51 AM -
JMIR Public Health Surveill. 2017 Sep 19;3(3):e58. doi: 10.2196/publichealth.7429.
Influenzanet: Citizens Among 10 Countries Collaborating to Monitor Influenza in Europe.
Koppeschaar CE1, Colizza V2, Guerrisi C2, Turbelin C2, Duggan J3, Edmunds WJ4, Kjelsø C5, Mexia R6, Moreno Y7, Meloni S7, Paolotti D8, Perrotta D8,...Today, 12:50 AM -
J Leukoc Biol. 2017 Sep 19. pii: jlb.5MA0517-207R. doi: 10.1189/jlb.5MA0517-207R. [Epub ahead of print]
Perturbed CD8+ T cell immunity across universal influenza epitopes in the elderly.
Nguyen THO1, Sant S1, Bird NL1, Grant EJ1,2,3, Clemens EB1, Koutsakos M1, Valkenburg SA1,4, Gras S3,5, Lappas M6,...Today, 12:47 AM
No content found
Show More
Please log in to your account to view your subscribed posts.
